— Know what they know.
Not Investment Advice

EXAI NASDAQ

Exscientia plc
1W: -13.7% 1M: -4.2% 3M: -14.8% 1Y: -16.8% 3Y: -77.2%
$4.84
Last traded 2024-11-20 — delisted
NASDAQ · Healthcare · Biotechnology · $633.2M mcap · 84M float · 0.840% daily turnover

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$20M -25.1% ▼
4Y CAGR: +13.9%
Gross Profit
-$7M -23.1% ▼
Operating Income
-$176M -23.1% ▼
Net Income
-$146M -25.0% ▼
EPS (Diluted)
$-1.18 -22.9% ▼
EBITDA
-$145M +9.0% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
Revenue$12M$13M$20M$27M$20M
YoY Growth+0.0%+10.4%+54.2%+32.0%-25.1%
Cost of Revenue$7M$19M$13M$33M$27M
Gross Profit$5M-$6M$8M-$6M-$7M
Gross Margin38.1%-47.1%37.6%-22.2%-36.5%
R&D Expenses$9M$15M$33M$127M$128M
SG&A Expenses$6M$12M$19M$38M$45M
Operating Expenses$14M$25M$49M$159M$169M
Operating Income-$10M-$32M-$41M-$143M-$176M
Operating Margin-81.3%-239.8%-203.5%-533.1%-876.6%
Interest Expense$50K$121K$169K$334K$1M
Income Before Tax-$11M-$33M-$42M-$138M-$162M
Tax Expense-$2M-$3M-$5M-$22M-$16M
Net Income-$8M-$30M-$37M-$117M-$146M
Net Margin-69.4%-230.4%-179.7%-435.3%-726.9%
EPS (Diluted)$-0.07$-0.25$-0.30$-0.96$-1.18
EBITDA-$7M-$23M-$52M-$160M-$145M
Shares Outstanding120M120M121M122M124M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms